10x Insights
Loading account…
Companies / Materials / Balchem Corporation
BCPC

Balchem Corporation

MaterialsChemicals
Ticker BCPCMONTVALE, NJFiscal year ends DecemberBook value per share $40.39Diluted shares 32.2M

Balchem Corporation (NASDAQ: BCPC) develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation and industrial markets. The company operates through three reportable segments: Human… From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$1.04B
+8.8% year over year
Last 12 mo $1.09B
20.18%
+1 percentage points
Last 12 mo 20.42%
$154.84M
+20.5% year over year
Last 12 mo $164.41M
12.31%
+1.1 percentage points
Last 12 mo 12.62%
Cash & financing
$216.56M
+19.0% year over year
Last 12 mo $219.62M
$173.07M
+18.3% year over year
Last 12 mo $171.36M
0.15
Was 0.18× a year earlier
Last 12 mo 0.14
32.6M
−0.3% year over year
Last 12 mo 32.2M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Balchem Corporation does

In the company’s own words

Balchem Corporation (NASDAQ: BCPC) develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation and industrial markets. The company operates through three reportable segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

The Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products for nutrition applications, recognizing choline's critical role in brain development and neural function. This segment also manufactures specialty vitamin K2 for bone and heart health, methylsulfonylmethane for joint and sports nutrition, and microencapsulation solutions for food and pharmaceutical applications. The segment serves beverage, bakery, dairy, confectionary and savory manufacturers with customized spray-dried and emulsified powders, extrusion and agglomeration capabilities, and cereal systems.

The Animal Nutrition and Health segment provides microencapsulated and chelated nutritional products, choline chloride for monogastric animals, and MSM for pet health. These products support ruminant milk production and enhance nutrient absorption across various animal species, serving the poultry, pet and swine industries globally.

The Specialty Products segment re-packages and distributes performance gases and chemicals including ethylene oxide for medical device sterilization, propylene oxide as a fumigant for nuts and spices, and ammonia for refrigeration and industrial applications. This segment also operates a micronutrient agricultural nutrition business selling chelated minerals to high-value crop producers through its patented Metalosate product line.

Balchem employs approximately 1,352 full-time employees worldwide and maintains manufacturing facilities across multiple countries. The company holds over 130 patents and 400 registered trademarks globally. The company's website is www.balchem.com. Balchem was incorporated in Maryland in 1967 and has built competitive advantages through proprietary microencapsulation and chelation technologies, extensive intellectual property, and strong manufacturing capabilities supporting diverse end markets and customer applications.

Company details
Sector
Materials
Industry (SIC)
Chemicals
Headquarters
MONTVALE, NJ
Fiscal year end
December
CIK
9326
SIC
2800

Financial performance, year by year

Fiscal 2013–2025 · USD
$-108.59M$217.18M$542.94M$868.70M$1.19B2013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Balchem Corporation — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

359
funds hold it
0 of 35
superinvestors hold it
$2.54B
held by funds, at market
48.0%
of shares held by funds

Largest fund holders · Balchem Corporation’s weight in each

iShares Core S&P Small-Cap ETF
IJR · iShares Trust
0.29%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.01%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.17%of fund net assets
VANGUARD SMALL-CAP INDEX FUND
VB · VANGUARD INDEX FUNDS
0.07%of fund net assets
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY · First Trust Exchange-Traded Fund VI
0.84%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Balchem Corporation and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Balchem Corporation's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Balchem Corporation's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.